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and unhealthy diets. Even in rural SA, associated diffusion of urban 
behaviours is fostering the CVD epidemic.(3)
The United Nations projects that the percentage of population 
above 60 years will more than double between 1999 and 2050 in 
SA, with the burden due to CVD predicted to become the prime 
contributor to total morbidity and mortality in the over 50-year age 
group.(4) However, CVD is taking its toll even amongst the younger 
age groups, with deaths projected to increase by over 40% in the 
35-to 64-year age group by 2030. This is further complicated by 
the growing number of HIV survivors, now estimated at 5.8% of 
the population older than 50 years.(5,6) 
This poses several challenges regarding the management of this 
emerging epidemic in the face of persisting undernutrition and 
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HEALTH POLICY 
AND CArDIO-
vASCuLAr DISEASE 
IntroductIon                                                               
Cardiovascular diseases (CVD) including, hypertension and stroke 
constitute an estimated 60% of all chronic non-communicable 
disease deaths worldwide.(1) In South Africa (SA), approximately 
195 people die per day due to CVD, representing about 20% of 
the daily deaths due to HIV/AIDS.(2) Several factors contribute to 
this trend. The first is an epidemiological transition, which has seen 
a rise in non communicable diseases. The transition in SA is dif-
ferent from other countries in that it is complicated by a persisting 
high burden of HIV/AIDS and TB, maternal and perinatal condi-
tions and growing burden of road traffic injuries. Other major 
factors include a demographic transition, urbanisation and globali-
sation, the latter through risk factors such as tobacco smoking 
the cardiovascular disease (cVd) burden in south Africa 
(sA) is increasing amongst all age groups and is predicted to 
become the prime contributor to overall morbidity and 
mortality in the over 50-year age group.  several factors 
contribute to this – an epidemiological transition, which has 
seen a rise in chronic non-communicable disease, and a 
demographic transition with much reduced fertility and a 
growing proportion of the population above 60 years.  In 
parallel with unfolding urbanisation, the population burden 
of vascular risk factors namely hypertension, hyper-
cholesterolemia, diabetes and obesity has increased.  the 
scale of cVd burden poses a threat to the health system 
and calls for timely intervention.  this paper discusses the 
burden of cVd in sA and current initiatives to address it. 
Evidence is presented from studies that focus on prevention 
including salt reduction and trans-fatty acids legislation.  the 
economic and clinical impact of an inadequate private and 
public sector response is summarised.  the paper documents 
lessons from other countries and proposes health systems 
strengthening measures that could improve care of patients 
with cVd.  SAHeart 2011; 8:48-57
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communicable diseases. It is particularly difficult because existing 
healthcare delivery structures are currently oriented towards acute 
care. In addition, funding for chronic healthcare has until now been 
oriented towards vertical management of HIV/AIDS. This situation 
calls for a review of current policies in order to ensure an 
appropriate and cost-effective management of cardiovascular 
disease.
The paper reviews strategies to address the CVD burden in SA. 
Some of these have been incorporated into policy and others bear 
scrutiny. The paper also addresses potential health system alter-
natives to improve the care of patients with CVD. We highlight 
the economic and clinical impact of an inadequate response and 
document cost-effective measures that could offer more efficient 
and effective use of scarce public sector resources. 
costs of cArdIoVAsculAr dIsEAsE                       
In 2003, cardiovascular disease cost the European Union €169 
billion(7) and $475.3 billion in direct and indirect annual costs in the 
USA in 2009.(8) Similar information is minimal in SA. Recent data 
shows that total costs of heart disease and stroke accounted for 
2 to 3% of the GDP of the country in 1991 (i.e. between R4 135 
billion and R5 035 billion).(9,10) Direct costs comprised 42% of 
the total, of which 75% was carried by the private sector.(10) 
Assuming a 4% rate of inflation, and a higher prevalence of CVD, 
the overall costs for CVD in 2010 would be more than double 
that 20 years ago. 
rIsk fActors In south AfrIcA                               
The major risk factors namely high blood pressure, tobacco use, 
high cholesterol, obesity, physical inactivity and unhealthy diets are 
increasingly prevalent in Africa, both in urban and rural settings.(11) 
The national prevalence of hypertension in sub-Saharan African 
countries (SSA) ranges from about 4% to 10%, with SA at the upper- 
end of this spectrum. The prevalence of hypertension amongst 
males and females in one rural Mpumalanga district was 44% 
and 42% respectively,(12) a figure much higher than that reported 
for other rural areas in SSA.(13)  Data from the same sub-district 
show an emerging trend of obesity and overweight amongst 
adolescent girls, suggesting the emergence of a nutritional transi-
tion characterised by a shift towards a higher caloric content diet 
and/or decline in physical activity.(3) Dietary changes coupled with 
lifestyle and occupational changes among adults, reinforced by 
widespread labour migration to urban centres is fostering the 
epidemic not only of high blood pressure and obesity but also 
stroke.(14) This trend is not confined to rural areas. A Soweto 
hospital-based study showed that 50% of all CVD patients present 
with hypertension, half of whom are obese.(15) 
GoVErnmEnt InItIAtIVEs And GuIdElInEs          
to AddrEss cVd 
Despite the growing burden of CVD and its potential catastrophic 
costs, there has been a limited health system response. This can 
be partially attributed to attention being focused on HIV/AIDS 
but government recognition and initiatives are gradually beginning 
to be targeted at chronic disease more broadly. In 1996, the 
Directorate of Chronic Diseases, Disabilities and Geriatrics was 
established within the National Department of Health. In 2006, 
this directorate developed national guidelines for the management 
and control of NCDs. The intent was to facilitate a cross-sectoral 
response to the NCD burden in line with the World Health 
Organisation’s Action Plan for 2008 to 2013.(16) 
Several disease specific guidelines for hypertension, chronic diseases 
of lifestyle (CDL) and for type 2 diabetes mellitus have been 
developed.(17,18) These guidelines provide information on the 
management and control and include interventions that have been 
shown to be cost-effective in middle and lower-income countries. 
However, available evidence suggests that primary prevention and 
management of common cardiac conditions is limited even with 
these guidelines “in place”.(19) 
Prioritisation of interventions for the primary prevention of chronic 
diseases is minimal. For example, the guideline on primary pre-
vention of CDL lists a variety of interventions for management. 
These interventions range from self-screening for weight control, 
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to the role of workplace support groups.(18) It is unclear what 
package of interventions should be adopted given the current 
resource envelope to ensure attainment of the highest health gains 
whether in urban or rural settings. 
The Department of Health has implemented standard treatment 
guidelines (STGs) and an Essential Drugs List (EDL) for treatment 
and management of CVD. Although drug supply remains proble-
matic, these guidelines have been instrumental in getting essential 
medicines to poorer and less accessible communities. Standard 
treatment guidelines enable more rational prescribing.(20) How- 
ever, the guidelines themselves warrant more careful scrutiny. For 
example, hypertension treatment guidelines are based solely on the 
blood pressure level approach in diagnosis and management of 
hypertension except where diabetes is a co-morbid condition.(21) 
Recent evidence suggests that focussing on one risk factor at a time 
may result in under-treatment of high-risk patients and possible 
over-treatment of lower-risk patients.(21) Instead the WHO is 
advocating for an absolute risk assessment approach which aims to 
balance several CVD risk factors present in an individual whilst 
promoting a healthy lifestyle.(22) There is evidence to suggest that 
this approach could have an enormous impact on the treatment of 
heart disease(23) and would be a more cost-effective way of 
managing CVD.(21) 
Whilst focus on CVD has been minimal, the revised South African 
guideline for managing ischaemic stroke and transient ischaemic 
attack is a notable step.(24) This guideline puts forward a protocol 
for management that considers both the current epidemiological 
context and the strength of evidence of interventions for stroke 
care. The comprehensive plan that spans across all aspects of care 
including primary prevention, acute management, secondary pre-
vention and rehabilitation, offers hope for mitigating the burden of 
disease due to stroke.
ApproAchEs to prEVEntIon                                        
Two approaches are conventionally advocated for CVD pre-
vention. Population-wide approaches targeting the entire popula-
tion and addressing the causes rather than the consequences; and 
those that target individuals who are at high risk or aimed at per-
sons with established disease. Population-based interventions that 
address socio-economic factors and change the context to make 
individuals’ default decisions healthy (Figure I) are the most effective 
as they tend to reach broader segments of society and require less 
individual effort.(25) Approaches directed at the individual using 
evidence-based clinical care though crucial are often limited by 
lack of access, erratic and unpredictable adherence levels and 
imperfect effectiveness in many health settings. Although a com-
bination of both approaches is a more effective way of preventing 
CVD, the following discussion is focused on specific population-
based approaches using Frieden’s health impact pyramid (Figure I) 
as the framework. It further highlights selected health systems 
strengthening initiatives that could improve the management of 
patients with CVD. 
populAtIon wIdE IntErVEntIons                            
Current policies – Tobacco legislation
Worldwide it is recognised that one of the most effective 
programmes for prevention of CVD is a comprehensive tobacco 
HEALTH POLICY AND CArDIOvASCuLAr DISEASE 
fIGurE 1:  The health impact pyramid according to Frieden (2010)
Increasing population 
impact
Increasing individual 
effort needed
Counselling  
& education
Clinical interventions
Long-lasting protective  
interventions
Changing the context to make  
individuals’ default decisions healthy
Socio-economic factors
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control programme, one which desirably contains most of the 
elements of the health impact pyramid.(25)  SA has been a leader 
in this regard, with the passing of the Tobacco Products Control 
Act of 1993. 
This legislation prohibited and/or restricted smoking in public 
places, regulated the sale and advertising of tobacco products and 
warning labels on tobacco packages. Most importantly, from both 
an effectiveness and cost-effectiveness perspective, the Govern-
ment increased tobacco taxes to 50% of the retail price of a pack 
of cigarettes in 1997.(26) Taxes were gradually increased to 52% in 
2002, where they now remain. Following this legislation, annual 
cigarette consumption fell by 33% from 1993 to 2003.(27) Consis-
tent with this trend has been a decline and stabilisation in the 
number of smoking-related CVD deaths.(28) Although the decline in 
CVD cannot be definitely attributed to the legislation, it is 
encouraging that the trend is in the expected direction. The impact 
of such legislation on resources saved has not been formally 
evaluated. However estimates from other countries suggest that as 
much as a few billion dollars could be saved annually.(29,30) In 2010 
the National Council Against Smoking (NCAS) urged the Minister 
of Finance to review tobacco tax rates in SA.(31) This advocacy 
group highlighted that SA's tax rates on tobacco were among the 
lowest in the world, thus emphasising that there is additional 
opportunity to benefit from tobacco legislation policy in SA. 
Potential for new policies – Salt reduction 
Modern diets contain many times the minimum daily require- 
ments of sodium, most of this coming from packaged foods and 
restaurant meals, making it difficult for individuals to control their 
intake.(25)  In SA, salt ingestion amongst all population groups 
exceeds international guidelines of <6g salt/day.(32) Close to 50% 
of this intake comes from non-discretionary sources, with bread 
as the single greatest contributor.(32) Evidence from around the 
world, including SA, equates salt reduction with a drop in blood 
pressure and a lower risk of CVD events.(33,34)  Recent data from 
the USA indicates that as little as a three grams per day decrease in 
salt intake could reduce annual healthcare costs attributable to 
cardiovascular disease by $10-24 billion annually.(35) 
While interventions that target salt reduction are key, dietary 
advice to reduce discretionary intake has little population im- 
pact.(34,36) One example of an effective cost-saving initiative is 
the “Tick” programme in Australia in which the salt content of 
selected processed foods is decreased.(36) In SA, Woolworths has 
reformulated several of its recipes to gradually reduce the salt 
content in making many of its brand products.(37) Both these 
examples rely on voluntary action by the food industry. However, 
evidence from Australia now shows that the population health 
benefits could be 20 times greater with government legislation to 
make the “Tick” programme mandatory.(36) All this evidence sug-
gests that polices to decrease the salt content of bread is an 
opportunity worth exploring in SA.(38)
Future policies – trans fatty acids 
The Department of Health is consulting with stakeholders on a 
proposed trans fatty acid Bill.(39) This Bill aims to reduce trans-fats 
present in certain processed and prepared foods currently for sale 
in SA. Because trans fatty acids significantly increase the risk of 
cardiovascular disease, the WHO recommends that trans fatty 
acids should be less than 1% of daily energy consumption. Currently, 
the oils in SA fast food outlets contain up to 25% of industrially 
produced trans fatty acids; most store-bought foods unless labelled 
otherwise contain trans fats.(40) Currently, the guidelines on 
Advertising and Labelling of Foodstuffs (under revision), which 
were promulgated under the Foodstuffs, Cosmetics and Dis-
infectants Act, 1972 (Act 54 of 1972) do not address the labelling 
of trans fats, in particular industrially produced trans fatty acids. 
Evidence from Denmark which implemented legislation banning 
the use of oils and fats containing more than 2% of industrially 
produced trans fatty acids in foods, shows that this method is 
effective in reducing trans fat intake.(39) In 2005, two years after 
Denmark implemented the legislation, a public surveillance pro-
gramme showed that it is impossible to ingest more than 1g of 
industrially produced trans fatty acids on a daily basis.(39) Even 
more encouraging is that this intervention is cost saving since 
it requires no consumer education. Generalising from such 
experiences the cost amounts to no more than US$0.50 per 
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person per year whilst the cost-effectiveness ratio for this 
intervention ranges from US$25 to US$73 per DALY* averted 
depending on the region.(41)
It is encouraging to note that the issue of trans fat acid intake is 
already on the policy agenda for SA. Even though the economic 
benefits from this intervention have not been formally evaluated, 
one can speculate that the decline in morbidity and mortality will 
have a positive impact on the costs to government of treating CVD. 
Community based Interventions 
A vital component of a successful prevention programme is 
community empowerment initiatives aimed at influencing social 
norms, health beliefs, and behaviours of the community.(42) Because 
personal lifestyle is socially conditioned, such interventions when 
effective will likely have a widespread positive impact on healthy 
behaviour change in society. Several community based inter-
ventions (CBIs) that could have an impact on chronic disease 
management have been initiated in SA (Table 1). However, most 
of these initiatives have been in localised settings, and were not 
taken to scale. Weak inter-sectoral action limits the effectiveness 
of these interventions. In addition studies to evaluate the benefit 
of CBIs in SA are rare, making it difficult to move towards a 
concerted programme of action.(43) Nonetheless, one study in the 
Western Cape showed that active community based intervention 
was effective in managing blood pressure control.(44) These findings 
are important since CVD is the leading cause of death among both 
men and women in the Western Cape Province, accounting for 
one in four deaths (25%).(45)
InItIAtIVEs wIthIn thE prIVAtE sEctor              
It is encouraging to note that the private industry, particularly 
private medical aid companies in SA are making strides towards 
CVD prevention. Discovery’s “Vitality” and Momentum’s “Multi-
ply” are rewards based wellness programmes that use diverse 
incentives to encourage healthy behaviour.(47,48) These program-
mes provide access to facilities for prevention including screening 
for CVD risk factors and for fitness. Members earn points for 
engaging in their health and are “rewarded” according to their 
level of engagement. Evidence from the Vitality Insured Persons 
(VIP) study showed that a high level of engagement is associated 
with both a reduction in admission rates and lower claims costs 
for cardiovascular conditions.(48) Nonetheless, membership to 
these programmes comes at an additional cost, and about 40% of 
Discovery Health beneficiaries are not on Vitality. 
Whilst Vitality is limited to beneficiaries, it is noteworthy that 
Discovery has increased its physical activity programmes beyond 
the private sector by funding and assisting the launch of the 
Discovery Healthy Lifestyle Programme (DHLP) in a rural setting 
of Limpopo.(49) DHLP comprises two components – “Health 
Nutz” and “Live it Up”. The former is focussed on school based 
physical activities incorporated into the school’s curriculum. The 
latter is a physical activity based programme that has been 
incorporated into chronic disease support group meetings held 
once a week at primary healthcare clinics. A qualitative evaluation 
of the programmes indicated a positive change in perception of 
physical activity in this community and growth in the “Live It Up” 
programme.(49) Several similar initiatives have been launched in 
1 000 public and private schools throughout SA. Such efforts are 
commendable in the fight against CVD. 
polIcy lEssons from othEr countrIEs            
As noted above, experience from other countries suggests that 
the most effective way to manage and control chronic diseases 
combines population-wide approaches and targeted, individual-
based approaches. Importantly, a suite of interventions, once 
fully implemented, will take at least five years to show any measur-
able effect. This timeframe accommodates both government and 
sub-national programmatic measures. Benefits to the popula- 
*DALYs for a disease or health condition are calculated as the sum of the Years of Life Lost (YLL) due to premature mortality in the population and the Years 
Lost due to Disability (YLD) for incident cases of the health condition. One DALY can be thought of as one lost year of "healthy" life. 
Su
m
m
er
 2
01
1
V
ol
um
e 
8 
• 
N
um
be
r 
1
53
tions following rapid wide-ranging improvements in diet and 
decreased calorie intake have been recorded in Finland,(50) USA,(51) 
and Poland.(52)
In Poland, mortality due to coronary heart disease fell drastically 
by about 26% between 1990 and 1994. This decline has con- 
tinued through 2002, with most of the decline attributed to a 
major increase in consumption of non-hydrogenated rapeseed 
and soya bean oil, rather than from reductions in smoking or an 
increase in fruit intake. Dietary legislation led to the replacement of 
dietary saturated fat with polyunsaturated fat. Vegetable fat and 
oil consumption also increased (primarily in the form of rape- 
seed and soybean oil products), while animal fat consumption, 
mainly butter declined. Price subsidies on butter were removed 
and cheaper vegetable oils made available. The result of this inter-
vention is one of the most dramatic rates of decline ever seen 
in Europe. 
tAblE 1: Community based interventions for chronic disease prevention(46)
Programme
Community Health 
Intervention Programme 
(CHIPs)(7)
Woolworths Health 
Promotion Programme
Soul City Health Promotion 
Programme
 Programme description
This health intervention programme was developed by the 
Sports Science Institute of SA (SSISA) in 1997 in response to the 
growing prevalence and burden of non-communicable diseases.
The aim of the programme is to promote health through the 
medium of regular physical activity.
Five programmes were designed to respond to needs of 
individuals through all phases of the life cycle.
The programmes are “Healthnutz” for children, “Optifit Out-
reach” for adults, “Fit for Work”, a workplace-based exercise 
intervention, “Live it  Up”  for  older adults and  “Wakey  Wakey”, 
which is a group-based  health awareness programme.
Each of these programmes embraces a two-fold strategy:  edu-
cation to increase awareness regarding the risk for developing 
chronic diseases of lifestyle; and regular physical activity to 
encourage adherence and self-efficacy in making healthier life-
style choices.
Working closely with schools and the  Department of Education, 
Woolworths in conjunction with SSISA, has developed the 
“Making the Difference through Nutrition Programme”.
This initiative combines outcomes-based education, interactive 
classroom activities and informative parent workshops, which 
positively influence the lifestyles and well-being of young 
learners and their communities.
One of the primary focuses of this initiative is to teach learners 
not only the importance of regular physical activity, but also 
how to become more physically active in a fun, creative and 
sustainable manner.
Soul City has run a television soap opera series with a health 
promotion programme, which targeted low-income groups. 
They also ran a sister radio programme for those without access 
to television.
These  included  health  messages  addressing  under- nutrition 
and overweight.
 Programme outcome
The programme has achieved the following:
Opened over 40 branches,  trained more than 300 leaders and 
impacted on 8 685 individuals’ lives.
The next phase of growth is to expand the programme nation-
ally and to develop a “train the trainer” model.
They are seeking accreditation from the South African Quali-
fications Authority (SAQA) for resource manuals and the training 
offered to leaders.
Woolworths and SSISA have produced a DVD to educate 
children, caregivers, parents and teachers about how to make 
physical activity an integral part of the lives of children.
In the DVD the presenters give valuable insights into the 
extensive benefits of physical activity, as well as practical advice 
on how to improve children’s physical activity levels at home and 
at school.
The 1km Health Track and the dynamic group dance (Dance 
for Fun), provide two inspiring examples of how exercise can 
be accessible and fun.
An extensive evaluation of the Soul City programme showed 
that it resulted in increased knowledge and awareness of high 
blood pressure, and adopting a healthy lifestyle to prevent and 
treat hypertension.
The programme was also associated with positive change in 
intention and actual behaviour.
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Another country that has reaped success from implementing a 
community-based intervention is Finland.(53) In 1972, this country 
had the world’s highest death rate from cardiovascular disease, 
which was attributed to heavy tobacco use, high fat diet and low 
vegetable intake. However, following the implementation of the 
broad community-based intervention, cancer and heart disease 
mortality decreased by close to 60% over 30 years and led to an 
increase in life expectancy in both men and women.(50,53) This broad 
community based intervention involved consumers and schools, 
as well as social and health services, and led to policies banning 
tobacco advertising, introduction of low fat and vegetable oil 
products, changes to farmers’ payment schemes and incentives 
for communities achieving the greatest reduction in cholesterol. 
The continual success of this programme could be attributed to 
several factors including nation-wide adoption of the programme.
(54) In addition to this community intervention, a transparent 
commitment by the Finnish government towards healthy dietary 
changes is another contributory factor. For example, until the early 
1970s, the government subsidised butter and whole cream and 
taxed margarine. In contrast a new law was passed in 1985 to 
allow low-fat spread and mixed butter and oils to compete 
through government subsidies. Furthermore screenings for cho-
lesterol for all people over 20 years of age were recom- 
mended every five years, a move that increased people’s interest 
in their diets.(55)
There is also evidence that workplace based interventions are 
a feasible and often successful means of improving health of 
employed adults. For example, the Johnson & Johnson Health and 
Wellness Programme in the United States provides preventive 
services and services during and after a major medical event to 
employees.(53) This approach has seen an improvement in eight 
out of 13 categories including tobacco use, cholesterol level, blood 
pressure and drinking habits.
hEAlth systEm chAnGEs                                          
A pre-requisite for effective implementation of prevention strate-
gies and identification of high-risk individuals is a functioning pri-
mary healthcare system.(42) Strengthening human resources to 
cope with the shifting burden of disease is a key component to 
strengthening primary healthcare. Due to severe shortages of 
health workers in SA, strategies that allow less specialised health 
workers to reliably and effectively assess and manage CVD in 
primary care settings are worth exploring.(42)  Equally important is 
the possibility of integrating the core components of prevention, 
screening and management of CVD risk factors within HIV clinics 
where routine assessment and management of patients has to 
date been comprehensive. 
Applying task shifting to managing CvD
There is evidence suggesting that strategies such as task shifting 
are effective in managing CVD.(55) A Canadian study found that 
a community pharmacist and nurse team can have a major effect 
on hypertension in patients with diabetes mellitus and sub-optimal 
BP control in the community.(56) SA has developed considerable 
experience of task shifting with respect to HIV/AIDS treatment 
and care. Available evidence indicates that mainstreaming uncom-
plicated HIV/AIDS care to lower-level cadres (specifically, nurses 
and adherence counsellors) in clinics improves quality of care,(57) 
access to care and adherence to medication.(57) Drawing from this 
experience, a task shifted model for cardiovascular disease 
management warrants exploring in SA. 
Integrating care – leveraging HIv services
Placement of integrated chronic care at the centre of primary 
healthcare systems will ensure a comprehensive response to one 
of the most important health problems confronting local commu-
nities.(58) Given the high burden of HIV /AIDS in SA, integration of 
care for patients with multiple chronic diseases is likely to decrease 
stigma associated with HIV whilst enhancing access and use to 
other chronic care services. Experience from Cambodia indicates 
that such an approach is feasible and could have the desired 
benefits.(59) However, before such an undertaking, it is crucial to 
understand whether the added complexity of integrated care 
could foster fragmentation of primary healthcare systems instead 
of invigorating it.(58)
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SA is beginning to develop experience with integrated chronic 
care through the PALSA PLUS initiative (Practical Approach to 
Lung Health and HIV/AIDS in South Africa) that combines 
evidence-based, locally adapted symptom and sign-based guide-
lines, with educational outreach.(60) This strategy is used to change 
the behaviour of health practitioners. The Western Cape and 
Free State are implementing it throughout their primary care 
facilities and this could provide a stepping-stone for integrating 
CVD management within TB and HIV clinics. Nonetheless, there 
is no evidence yet regarding the cost or cost-effectiveness of such 
an initiative. 
rEcommEndAtIons                                                     
In the face of scarce healthcare resources and an underper- 
forming healthcare system, SA can do much more to address 
CVD. This includes implementing and reviewing legislation that 
takes a population-wide approach. The draft bill on trans fat is a 
step in the right direction for SA. 
A front-of-pack food labelling traffic light system where red = bad/
unhealthy, and green is good/healthy (with amber between the 
two), with respect to levels of salt, fat, saturated fat, sugar and 
other nutrients, is worth considering.(61) This approach is not only 
easy for the consumer to understand but avoids the problems 
likely to be encountered when developing an effective educational 
campaign for a diversity of consumers. Nonetheless, because of the 
potential to harm lucrative sales from junk food and ready meals 
(which are often laden with cheaper sugar, salt and fat laden 
ingredients), such a strategy is likely to encounter opposition from 
food manufactures and their shareholders with vested interests. 
There are compelling grounds to integrate the management of 
HIV/AIDS with care for other chronic conditions such as diabetes 
and hypertension in SA. Since adherence levels and patient 
management are generally stronger within HIV clinics, one might 
predict that patient outcomes for CVD would also improve with 
a similar approach. However, in planning for such an undertaking, 
it will be crucial to perform operational research into the specifics 
of managing particular diseases and risk factors.(27) 
conclusIons                                                                   
The burden of cardiovascular disease is growing in SA. Responding 
to the burden of CVD is in line with a recent United Nations 
resolution that seeks to halt the increasing trends in premature 
deaths from non communicable diseases.(62) Reversing the emerg-
ing epidemic will take more than just targeting individuals, their 
behaviours and lifestyle choices. Emphasis should be placed on 
population-wide policy development that supports a change in 
the health context to encourage healthy personal decisions. 
Healthier food environments through salt reduction in packaged 
foods and legislation on trans fats, could have a considerable im-
pact. Whilst SA has been a leader with respect to tobacco 
legislation, tobacco consumption and smoking has now stabilised 
at an unacceptably high level. Without careful review of current 
policy and best practices for managing CVD on several fronts, 
opportunities to curb a potential catastrophe will be missed. 
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